These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 459526)

  • 21. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
    Franciosa JA; Pierpont G; Cohn JN
    Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
    Chatterjee K; Ports TA; Brundage BH; Massie B; Holly AN; Parmley WW
    Ann Intern Med; 1980 May; 92(5):600-4. PubMed ID: 7386999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of oral hydralazine on rest and exercise hemodynamics in patients with aortic or mitral regurgitation and left ventricular dysfunction.
    Slosky DA; Hindman MC; Peter RH; Wallace AG
    Clin Cardiol; 1981; 4(4):162-7. PubMed ID: 7273499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative enhancement of left ventricular performance by combined inotropic-vasodilator therapy with preload control.
    Miller DC; Stinson EB; Oyer PE; Derby GC; Reitz BA; Shumway NE
    Surgery; 1980 Jul; 88(1):108-17. PubMed ID: 7385014
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of vasodilators on canine cardiopulmonary function when a decrease in cardiac output complicates an increase in right ventricular afterload.
    Ghignone M; Girling L; Prewitt RM
    Am Rev Respir Dis; 1985 Apr; 131(4):527-30. PubMed ID: 3994147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous hydralazine infusion for afterload reduction.
    Swartz MT; Kaiser GC; Willman VL; Codd JE; Tyras DH; Barner HB
    Ann Thorac Surg; 1981 Aug; 32(2):188-92. PubMed ID: 7259359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
    Mehta J; Pepine CJ; Conti CR
    Clin Cardiol; 1978 Aug; 1(2):68-73. PubMed ID: 116791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should continuous hydralazine infusions be utilized in severe pregnancy-induced hypertension?
    Kirshon B; Wasserstrum N; Cotton DB
    Am J Perinatol; 1991 May; 8(3):206-8. PubMed ID: 2029282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
    Rubin LJ; Peter RH
    Am J Cardiol; 1981 Jan; 47(1):116-22. PubMed ID: 7457397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precipitation of heart failure following sudden withdrawal of hydralazine.
    Black JR; Mehta J
    Chest; 1979 Jun; 75(6):724-5. PubMed ID: 436528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    Mehta J; Iacona M; Pepine CJ; Conti CR
    Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydralazine in chronic CHF.
    Chatterjee K; Rouleau JL; Massie BM
    Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
    Haitas B; Meyer TE; Angel ME; Reef E
    Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
    Shepherd AM; Irvine NA
    J Cardiovasc Pharmacol; 1986; 8(3):527-33. PubMed ID: 2425168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hydralazine and nitroprusside on cardiopulmonary function when a decrease in cardiac output complicates a short-term increase in pulmonary vascular resistance.
    Lee KY; Molloy DW; Slykerman L; Prewitt RM
    Circulation; 1983 Dec; 68(6):1299-303. PubMed ID: 6640879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
    Rubin LJ; Handel F; Peter RH
    Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.